Matters of Scale - Fit for Public Consumption

bullet
Amount of money U.S. drug companies spent on marketing in 1999
$14 billion
Amount of money the 12 largest drug companies spent on research and development that year
$19 billion
bullet
Amount that BP (formerly British Petroleum) is spending annually to market its new name and its new environmentally friendly image of moving "beyond petroleum"
$100 million
Amount that BP invests annually in clean energy (solar, wind, etc.) each year
$100 million
bullet
U.S. military sending on the war in Afghanistan
at least $2.5 billion
U.S. government spending on emergency humanitarian aid to Afghanistan
$0.320 billion
bullet
U.S. funding for Plan Colombia, which aims to halt illicit coca production largely through military funding and aerial spraying of herbicides
$1.3 billion
Share of this funding dedicated to helping Colombian farmers shift to legal crops
$0.081 billion
bullet
Wholesale price, per pill, Bayer Corporation charges for the anthrax-fighting antibiotic Cipro
$4.67
Approximate price that generic drugmakers say they could profitably charge for making the drug
$0.40
bullet
Sources: Public Citizen report, “Analysis of Pharmaceutical Industry Corporate Profits, 1999,” 6 October 2000; “Dinner’s On You,” All Things Considered, NPR, 23 July 2001; “BP Amoco Unveils New Global Brand to Drive Growth,” BP Press Release, 24 July 2000; Innovest Strategic Value Advisors, Climate Change and Shareholder Value: Case Study of BP (New York: 2001); “War experts: U.S. Campaign Cost-Effective,” CNN.com, 14 December 2001; “Fighting Terror/Aiding a Nation; U.S. Cost to Rebuild Afghanistan at Issue,” The Boston Globe, 9 January 2002; “Stepped Up Battle Against Coca Ignites Debate,” The Miami Herald, 16 April 2001; “Medicine as a Luxury,” The American Prospect: Globalism and Poverty supplement, winter 2002.